Calcitonin gene-related peptide receptor antagonist ubrogepant for the treatment of acute migraine
Sign Up to like & getrecommendations! Published in 2021 at "Medicine"
DOI: 10.1097/md.0000000000024741
Abstract: Abstract Background: The objective of this study is to systematically evaluate the efficacy and safety of the calcitonin gene-related peptide (CGRP) receptor antagonist ubrogepant for the treatment of acute migraine. Methods: Randomized controlled trials (RCTs)… read more here.
Keywords: treatment acute; acute migraine; calcitonin gene; ubrogepant treatment ... See more keywords